| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2026 | 709.45% |
Sandisk (SNDK) | 2026 | 230.03% |
Dell Technologies (DELL) | 2026 | 149.42% |
Frontline (FRO) | 2026 | 142.19% |
Marathon Petroleum (MPC) | 2026 | 134.39% |
Oscar Health (OSCR) | 2026 | 129.62% |
Micron Technology (MU) | 2026 | 122.57% |
Revolution Medicines (RVMD) | 2026 | 121.26% |
Valero Energy (VLO) | 2026 | 118.33% |
HF Sinclair (DINO) | 2026 | 117.52% |
Okta (OKTA) | 2026 | 96.4% |
Phillips 66 (PSX) | 2026 | 95.51% |
SharkNinja (SN) | 2026 | 93.62% |
Glaukos (GKOS) | 2026 | 92.17% |
Bloom Energy (BE) | 2026 | 84.96% |
Advanced Micro Devices (AMD) | 2026 | 84.74% |
Equinor ASA ADR (EQNR) | 2026 | 84.37% |
Hewlett Packard Enterprise (HPE) | 2026 | 84.05% |
Crowdstrike (CRWD) | 2026 | 83.29% |
APA (APA) | 2026 | 81.95% |
Halozyme Therapeutics (HALO) | 2026 | 81.6% |
Life Time (LTH) | 2026 | 80.87% |
Centene (CNC) | 2026 | 80.11% |
ASE Industrial Holding Co Ltd ADR (ASX) | 2026 | 80.08% |
Royalty Pharma (RPRX) | 2026 | 77.02% |
Large-cap stocks are treated as having a market cap of $10B+.